Moexipril Hydrochloride and Hydrochlorothiazide - Moexipril Hydrochloride and Hydrochlorothiazide
Navigation: NDC > Supplier starting with: P > PADDOCK LABORATORIES, INC.| Field | Value |
|---|---|
| NDC Code: | 0574-0133 |
| Proprietary Name: | Moexipril Hydrochloride and Hydrochlorothiazide |
| Suffix: | |
| Non-Proprietary Name: | Moexipril Hydrochloride and Hydrochlorothiazide |
| Dosage Form: | TABLET, COATED |
| Method: | ORAL |
| Original Marketing Date: | 01-07-2009 |
| Category Name: | ANDA |
| Application Number: | ANDA090096 |
| Labeler: | PADDOCK LABORATORIES, INC. |
| Substance Name: | HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE |
| Active Numerator Strength: | 12.5; 7.5 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| DEA Schedule: |